Sponsor:
Children's Oncology Group
Code:
NCT05602194
Conditions
B Acute Lymphoblastic Leukemia
B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1
B Acute Lymphoblastic Leukemia, BCR-ABL1-Like
Lymphoblastic Lymphoma
Mixed Phenotype Acute Leukemia
Eligibility Criteria
Sex: All
Age: 15 - 40
Healthy Volunteers: Not accepted
Interventions
Biospecimen Collection
Calaspargase Pegol
Levocarnitine
Pegaspargase
Quality-of-Life Assessment
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-04-24. This information was provided to ClinicalTrials.gov by Children's Oncology Group on 2025-03-19.